论文信息 - Serological cloning of PARIS-1: a new TBC domain-containing, immunogenic tumor antigen from a prostate cancer cell line. - 字舞流文

Serological cloning of PARIS-1: a new TBC domain-containing, immunogenic tumor antigen from a prostate cancer cell line.

S. J. Monahan | A. Boynton | M. Salgaller | Yaling Zhou | M. Toth | M. Hamman | P. Lodge | M.Shane Hamman